In DepthBiomedicine

Replumbing the lymphatic system

See allHide authors and affiliations

Science  12 Oct 2018:
Vol. 362, Issue 6411, pp. 140-141
DOI: 10.1126/science.362.6411.140

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Researchers have begun to test potential treatments for lymphedema, a condition in which lymphatic fluid doesn't drain normally from a limb or other part of the body. Although some cases are inherited, most patients develop lymphedema because of cancer treatment or parasite infections, and the pent-up lymph can cause swelling, fibrosis, and fat accumulation. No treatments have been able to spur the regrowth of lymphatic vessels. One phase II trial that recently wrapped up was testing a drug called ubenimex that blocks a lipid molecule that prevents lymph vessel regeneration. A second trial is using gene therapy to stimulate new lymphatic vessel growth in patients who developed lymphedema because of breast cancer surgery.